Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial comparing vonoprazan-based triple therapy to esomeprazole-based triple therapy for Helicobacter pylori eradication. T…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer [Phase 4]
This Phase 4 clinical trial is evaluating the efficacy and safety of fexuprazan to prevent NSAID-induced peptic ulcers; the study is current…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers [Phase 4]
A Phase 4 clinical trial at the Chinese University of Hong Kong is comparing intravenous proton pump inhibitor infusion with oral PPIs for t…
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound
A clinical trial evaluating whether Helicobacter pylori serology and gastric ultrasound can predict peptic complications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Onyx™ Liquid Embolic IDE Clinical Study [NA]
An IDE clinical study evaluating Onyx Liquid Embolic by Medtronic Endovascular for hemorrhage-related conditions is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study
A community-wide population-based study in Lao PDR on Helicobacter pylori infection and gastric diseases has completed, assessing eradicatio…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis [Phase 4]
A Phase 4 comparative effectiveness trial evaluating triple-therapy versus quadruple-therapy regimens for Helicobacter pylori–induced gastri…
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support [NA]
A UCLA-sponsored clinical trial seeks to optimize proton pump inhibitor prescribing using electronic health record decision support and to s…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 4]
A Phase 4 trial is evaluating Saccharomyces boulardii in combination with bismuth quadruple therapy as a rescue treatment for Helicobacter p…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease [NA]
This clinical trial outlines treatment regimens with and without bismuth for Helicobacter pylori-associated peptic ulcer disease in children…
-
FDA approval · 2025-11-21FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination therapy Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlori…
-
FDA approval · 2025-10-31FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan and amoxicillin from Phathom Pharmaceuticals,…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia [Phase 4]
Phase 4 clinical trial evaluating a 14-day Modified Bismuth Quadruple Therapy for Helicobacter pylori eradication in areas with high resista…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Ulcer Pomegranate Muffins [NA]
Clinical trial on ulcer-related outcomes using pomegranate muffins sponsored by the University of Lahore has completed.
-
FDA approval · 2025-08-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application to market generic lansoprazole.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial [Phase 4]
Phase 4 clinical trial evaluating vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication, curren…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment [NA]
A clinical trial evaluating healing of marginal ulcers after Roux-en-Y procedures using low-thermal argon plasma endoscopic therapy; current…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Precise Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Bleeding: A Randomized Controlled Trial [NA]
This randomized controlled trial evaluated endoscopic application of tranexamic acid and sucralfate for bleeding peptic ulcers and has compl…
-
FDA approval · 2025-07-16FDA Approved: FAMOTIDINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for famotidine from Sagent Pharmaceuticals, marking the approval of a generic product.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology [Phase 4]
Phase 4 trial evaluating the effects of high-dose dual therapy and bismuth quadruple therapy for Helicobacter pylori eradication on intestin…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing Vonorazon plus Amoxicillin dual therapy versus a bismuth-containing quadruple regimen for Helicobacter pylori-relate…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Prevention of Postoperative Hernias in Emergency Surgery
This clinical trial update describes a study evaluating methods to prevent postoperative hernias after emergency surgery, enrolling patients…
-
FDA approval · 2025-06-12FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak, a three-drug regimen (vonoprazan fumarate, amoxicillin, and clarithromy…